Campbell & Co Investment Adviser’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.69M | Buy |
34,593
+27,160
| +365% | +$7.14M | 0.51% | 10 |
|
|
2026
Q1 | $1.98M | Sell |
7,433
-32,519
| -81% | -$8.81M | 0.11% | 277 |
|
|
2025
Q4 | $10M | Buy |
39,952
+33,100
| +483% | +$8.79M | 0.48% | 14 |
|
|
2025
Q3 | $1.97M | Buy |
+6,852
| New | +$1.84M | 0.15% | 192 |
|
|
2025
Q2 | – | Sell |
-37,513
| Closed | -$8.73M | – | 1309 |
|
|
2025
Q1 | $8.73M | Buy |
37,513
+36,622
| +4,110% | +$8.89M | 0.67% | 2 |
|
|
2024
Q4 | $204K | Sell |
891
-17,260
| -95% | -$3.96M | 0.02% | 963 |
|
|
2024
Q3 | $4.06M | Buy |
18,151
+13,643
| +303% | +$3M | 0.3% | 56 |
|
|
2024
Q2 | $917K | Sell |
4,508
-15,660
| -78% | -$3.19M | 0.08% | 399 |
|
|
2024
Q1 | $4.41M | Buy |
20,168
+7,982
| +66% | +$1.76M | 0.38% | 25 |
|
|
2023
Q4 | $2.77M | Buy |
12,186
+4,819
| +65% | +$1.01M | 0.25% | 62 |
|
|
2023
Q3 | $1.48M | Buy |
+7,367
| New | +$1.55M | 0.18% | 158 |
|
|
2023
Q2 | – | Sell |
-2,429
| Closed | -$479K | – | 1016 |
|
|
2023
Q1 | $479K | Buy |
2,429
+80
| +3% | +$16.5K | 0.09% | 441 |
|
|
2022
Q4 | $475K | Sell |
2,349
-136
| -5% | -$26.6K | 0.11% | 337 |
|
|
2022
Q3 | $437K | Buy |
+2,485
| New | +$509K | 0.1% | 357 |
|
|
2022
Q2 | – | Sell |
-1,590
| Closed | -$360K | – | 805 |
|
|
2022
Q1 | $360K | Buy |
1,590
+342
| +27% | +$80.4K | 0.1% | 403 |
|
|
2021
Q4 | $337K | Sell |
1,248
-1,106
| -47% | -$274K | 0.12% | 315 |
|
|
2021
Q3 | $569K | Buy |
2,354
+815
| +53% | +$205K | 0.19% | 176 |
|
|
2021
Q2 | $365K | Buy |
1,539
+404
| +36% | +$92K | 0.15% | 252 |
|
|
2021
Q1 | $249K | Buy |
+1,135
| New | +$228K | 0.15% | 287 |
|
|
2020
Q3 | – | Sell |
-2,267
| Closed | -$324K | – | 437 |
|
|
2020
Q2 | $324K | Buy |
+2,267
| New | +$314K | 0.41% | 90 |
|
|
2020
Q1 | – | Sell |
-4,001
| Closed | -$581K | – | 290 |
|
|
2019
Q4 | $581K | Sell |
4,001
-2,599
| -39% | -$375K | 0.18% | 186 |
|
|
2019
Q3 | $953K | Buy |
6,600
+4,937
| +297% | +$720K | 0.36% | 42 |
|
|
2019
Q2 | $247K | Buy |
+1,663
| New | +$232K | 0.11% | 388 |
|
|
2019
Q1 | – | Sell |
-5,013
| Closed | -$603K | – | 564 |
|
|
2018
Q4 | $603K | Buy |
+5,013
| New | +$672K | 0.59% | 13 |
|
|
2018
Q2 | – | Sell |
-1,550
| Closed | -$215K | – | 460 |
|
|
2018
Q1 | $215K | Buy |
+1,550
| New | +$228K | 0.18% | 285 |
|
|
2015
Q4 | – | Sell |
-6,553
| Closed | -$611K | – | 158 |
|
|
2015
Q3 | $611K | Buy |
+6,553
| New | +$678K | 0.41% | 75 |
|
Other funds holding LH
Campbell & Co Investment Adviser's LH Position: Q2 2026 in Review
Campbell & Co Investment Adviser increased its Labcorp (LH) stake by 365% in Q2 2026, buying an estimated $7.14M and bringing the position to 34,593 shares worth $9.69M. The position accounts for 0.51% of the portfolio, ranked #10.
Campbell & Co Investment Adviser first reported a position in LH in Q3 2015 and has held it in 26 quarters since. The position peaked at $10M in Q4 2025. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Campbell & Co Investment Adviser held 34,593 shares of Labcorp worth $9.69M as of Q2 2026.
- Campbell & Co Investment Adviser bought 27,160 Labcorp shares in Q2 2026, an estimated $7.14M.
- Labcorp made up 0.51% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #10 holding.
- Campbell & Co Investment Adviser first reported a position in Labcorp in Q3 2015 and has held it in 26 quarters since.
- Campbell & Co Investment Adviser's Labcorp position peaked at $10M in Q4 2025.
- 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.